Case File
efta-efta00365543DOJ Data Set 9OtherFrom: Lesley Groff
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00365543
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Lesley Groff
To: Jeffrey Epstein <[email protected]>
Subject: Fwd: Vesselon Overview Documents
Date: Mon, 11 Aug 2014 11:49:42 +0000
Sent from my iPhone
Begin forwarded message:
From: "Don Spongberg" <
Date: August 8, 2014, 12:03:45 PM EDT
To:
Subject: Vesselon Overview Documents
Reply-To: "Don Spongberg"
Dear Jeffrey,
I am pleased to present the market collateral for Vesselon, Inc.
• Executive Overview
• One Page Overview
• Investor Presentation
Vessebn is a development stage company that is developing and will seek to market the
world's first portable devices for the immediate treatment of ischemic stroke — the most
common type of stroke, which occurs when a blood vessel supplying blood to the brain is
blocked by a blood clot.
Vessebn believes their potential device, which can be compared to an automated external
defibrillator ("AED") for stroke, is distinct from all current or experimental therapies. Their
noninvasive device is aimed to treat ischemic stroke victims by working to dissolve blood clots
before or as victims arrive at a hospital - critical because minutes matter to save lives.
Prolonged delay in restoring blood flow to affected areas of the brain after an ischemic stroke
may result in severe or permanent incapacitation, paralysis, loss of speech or cognitive
function. Just as AEDs now save cardiac arrest patients' lives, Vesselon believes their
proposed immediate ischemic stroke treatment device has the potential to save lives, improve
patient outcomes and reduce healthcare costs.
I look forward to speaking with you further about the Vesselon opportunity. I will be pleased to
provide you with a copy of the confidential Private Placement Memorandum upon request.
EFTA00365543
Don Spongberg
Senior Managing Director
Spencer Trask Ventures
Member FINRA & SIPC
INVESTMENTS IN THIS OFFERING SHALL BE RESTRICTED SOLELY TO ACCREDITED INVESTORS THAT HAVE BEEN
VERIFIED BY THE COMPANY AND THE PLACEMENT AGENT IN ACCORDANCE WITH RULE 506(C) UNDER THE SECURITIES
ACT OF 1933. AS AMENDED.
FOR INFORMATION PURPOSES ONLY. The information contained herein does not constitute an offer to sell or a solicitation of an
offer to buy any security in Vesselon. Inc. (the 'Company'). An offer can be made only pursuant to the Confidential Private Placement
Memorandum of the Company. and only in stales in which the offering of the securities is registered. or is exempt from registration and
only by broker-dealers authorized to do so.
To the extent an inconsistency exists between this material and the Company's Confidential Private Placement Memorandum. dated
July 30.2014. as the same may be amended. supplemented or otherwise modified from time to time (the -PPM"). the disclosure in the
PPM shall control.
Click here to manage your email subscriptions. View the online version of this email.
Spencer Trask Ventures. Inc.
Member F/NRA & SIPC
1140 Avenue of the Americas. 9th Floor. New York. NY 10036
1700 East Putnam Avenue. Suite 302. Old Greenwich. CT 06870
EFTA00365544
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.